XML 20 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities:    
Net income $ 85,317 $ 230,955
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 143,495 110,054
Amortization of debt issuance costs 3,513 3,061
Equity-based compensation expense 25,257 27,014
Deferred income taxes 3,309 56,133
Debt extinguishment costs 1,269  
Legal settlements expense 3,504  
Loss on impairment 1,452 11,459
Gain on sale of property (8,715)  
Other 1,907 (3,988)
Change in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable, net (64,958) (20,936)
Other current assets (17,590) (3,334)
Other assets (10,865) 676
Accounts payable and other accrued liabilities 33,584 (404,942)
Accrued salaries and benefits 5,158 (1,841)
Other liabilities 12,554 8,681
Net cash provided by operating activities 218,191 12,992
Investing activities:    
Cash paid for acquisitions, net of cash acquired (8,165) (53,550)
Cash paid for capital expenditures (478,617) (486,891)
Proceeds from sale of property and equipment 23,151 10,227
Other (145) (2,935)
Net cash used in investing activities (463,776) (533,149)
Financing activities:    
Borrowings on long-term debt 1,200,000 350,000
Principal payments on revolving credit facility (1,035,000) (15,000)
Principal payments on long-term debt (8,125) (40,968)
Repayment of long-term debt (670,856)  
Payment of debt issuance costs (18,615) (1,518)
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (3,953) (824)
Repurchase of common stock (50,034)  
Contributions from noncontrolling partners in joint ventures 5,000 3,500
Distributions to noncontrolling partners in joint ventures (3,877) (2,972)
Cash paid for contingent consideration (1,500)  
Other (67) 11
Net cash provided by financing activities 287,973 502,229
Net increase (decrease) in cash and cash equivalents 42,388 (17,928)
Cash and cash equivalents at beginning of the period 76,305 100,073
Cash and cash equivalents at end of the period 118,693 82,145
Effect of acquisitions:    
Assets acquired, excluding cash 36,715 59,235
Liabilities assumed (1,193) (4,185)
Contingent consideration issued in connection with an acquisition   (1,500)
Redeemable noncontrolling interest resulting from an acquisition (27,357)  
Cash paid for acquisitions, net of cash acquired 8,165 53,550
New Credit Facility [Member]    
Financing activities:    
Borrowings on revolving credit facility $ 875,000 $ 210,000